Pill Connect

Pill Connect builds digital tracking devices to monitor medication adherence in clinical trials.

Manchester, UK—Founded 2019—Website

£261MTotal raised

Manchester medtech business that has developed a digital tracking device to monitor medication adherence in clinical trials. The reusable technology attaches to standard pill bottles to supply real-time dispensing data to pharmaceutical companies.

Team

James Burnstone

CEO

Investors

13 February 2025
£260M
GL
GMC Life Sciences Fund By Praetura
NI
NPIF II – Praetura Equity Finance
Seed3 November 2020
£510K
JM
Jonathan MilnerLead
Catapult Ventures
SP
Shallcross Partners

Funding history

13 February 2025

£260M

Pill Connect secures new funding from Praetura Ventures to scale its medical adherence technology.

The Manchester medtech company raised backing from the GMC Life Sciences Fund and NPIF II to expand its team and fulfill commercial contracts.

Seed3 November 2020

£510K

Pill Connect secures £510k in Series A follow on funding led by Jonathan Milner to prepare for commercial launch.

The funding round was backed by Jonathan Milner, Catapult Ventures and Shallcross Partners to fund regulatory submissions and commercialisation.